tradingkey.logo
tradingkey.logo
Search

Dianthus Therapeutics Inc

DNTH
Add to Watchlist
106.920USD
-5.720-5.08%
Close 07-31 16:00ETQuotes delayed by 15 min
5.84BMarket Cap
LossP/E TTM

DNTH Financials

See Dianthus Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Dianthus Therapeutics Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
-0.85/-1.07
Revenue / Forecast
463.00K/354.21K
Period
FY2025 Earnings
Revenue(YoY)
2.04M
-67.35%
EPS(YoY)
-4.20
-64.82%
Analyst Rating
STRONG BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-3.10%-0.85
-78.11%-1.43
-32.30%-0.97
-71.64%-0.88
-53.93%-0.82
-13.47%-0.80
80.54%-0.74
95.96%-0.51
93.39%-0.54
86.71%-0.71
---3.78
---12.73
---8.10
---5.33
----
----
----
----
----
----
Revenue
-60.19%463.00K
-78.58%284.00K
-81.77%396.00K
-89.64%193.00K
33.07%1.16M
190.15%1.33M
135.06%2.17M
92.26%1.86M
83.61%874.00K
--457.00K
--924.00K
--969.00K
--476.00K
----
----
----
----
----
----
----
Net Profit
-38.37%-40.83M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
47.65%-10.56M
8.09%-14.76M
35.50%-11.14M
69.11%-7.09M
-4.59%-20.18M
7.83%-16.06M
-2.03%-17.27M
-31.23%-22.95M
-6.19%-19.29M
1.42%-17.43M
11.27%-16.93M
Net Margin
-247.57%-8819.44%
-957.78%-22687.32%
-701.03%-9284.09%
-1634.03%-16388.08%
-61.32%-2537.49%
7.21%-2144.80%
27.46%-1159.02%
17.79%-945.09%
-5.62%-1573.00%
---2311.38%
---1597.73%
---1149.64%
---1489.29%
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
Revenue
-60.19%463.00K
-78.58%284.00K
-81.77%396.00K
-89.64%193.00K
33.07%1.16M
190.15%1.33M
135.06%2.17M
92.26%1.86M
83.61%874.00K
--457.00K
--924.00K
--969.00K
--476.00K
----
----
----
----
----
----
----
Operating profit
-40.26%-46.53M
-117.89%-69.54M
-34.74%-40.29M
-57.30%-34.93M
-85.93%-33.18M
-146.34%-31.92M
-89.73%-29.90M
-88.55%-22.20M
-132.25%-17.84M
40.38%-12.96M
8.66%-15.76M
34.88%-11.78M
67.76%-7.68M
-7.90%-21.73M
5.44%-17.25M
-2.69%-18.08M
-27.47%-23.83M
-5.64%-20.14M
0.74%-18.25M
12.00%-17.61M
Net Profit
-38.37%-40.83M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
47.65%-10.56M
8.09%-14.76M
35.50%-11.14M
69.11%-7.09M
-4.59%-20.18M
7.83%-16.06M
-2.03%-17.27M
-31.23%-22.95M
-6.19%-19.29M
1.42%-17.43M
11.27%-16.93M
Current assets
313.25%1.12B
45.76%409.44M
43.94%413.82M
-27.92%263.61M
-28.86%271.00M
58.30%280.90M
50.16%287.49M
365.03%365.69M
356.52%380.93M
53.50%177.45M
44.93%191.45M
-44.64%78.64M
-47.93%83.44M
-36.02%115.60M
-32.77%132.10M
-32.42%142.04M
18.61%160.24M
19.25%180.69M
19.61%196.47M
16.85%210.19M
Total current liabilities
125.82%38.28M
66.55%30.73M
51.85%23.86M
100.35%20.09M
89.23%16.95M
91.59%18.45M
20.12%15.71M
148.61%10.03M
49.77%8.96M
-33.80%9.63M
1.22%13.08M
-64.16%4.03M
-57.55%5.98M
33.93%14.55M
27.34%12.92M
1.56%11.26M
53.08%14.09M
-4.96%10.86M
2.87%10.15M
6.89%11.08M
Total assets
257.70%1.25B
41.95%530.92M
63.01%577.45M
-11.62%326.08M
-8.86%348.58M
108.47%374.01M
84.06%354.25M
369.19%368.96M
358.36%382.46M
22.34%179.41M
17.27%192.46M
-55.10%78.64M
-57.07%83.44M
-22.79%146.65M
-20.42%164.12M
-20.54%175.12M
34.41%194.38M
17.52%189.93M
18.09%206.24M
15.55%220.38M
Total liabilities
128.15%45.57M
74.27%37.52M
89.55%30.99M
114.10%23.00M
104.34%19.97M
104.38%21.53M
16.11%16.35M
166.26%10.74M
63.41%9.78M
-74.11%10.54M
-64.88%14.08M
-89.77%4.03M
-86.15%5.98M
135.70%40.69M
142.31%40.10M
125.57%39.44M
177.60%43.20M
-2.55%17.26M
2.94%16.55M
4.00%17.49M
Total equity
265.58%1.20B
39.98%493.40M
61.72%546.45M
-15.39%303.08M
-11.83%328.61M
108.73%352.48M
89.42%337.90M
380.16%358.22M
381.14%372.69M
59.37%168.87M
43.83%178.38M
-45.01%74.60M
-48.77%77.46M
-38.64%105.96M
-34.62%124.03M
-33.13%135.68M
17.15%151.19M
19.99%172.67M
19.63%189.69M
16.66%202.89M
Net operating income
-4.44%-28.86M
-71.20%-46.98M
-43.67%-30.55M
-64.45%-23.89M
-84.93%-27.63M
-131.52%-27.44M
-224.11%-21.27M
-207.08%-14.53M
-45.28%-14.94M
28.97%-11.85M
224.10%17.14M
71.93%-4.73M
47.91%-10.28M
-6.36%-16.69M
1.84%-13.81M
-29.64%-16.85M
-17.69%-19.74M
-14.25%-15.69M
2.50%-14.07M
32.31%-13.00M
Net investment
-1005.59%-133.97M
260.98%37.20M
22.40%-201.28M
2162.19%26.45M
368.64%14.79M
-180.56%-23.11M
-1436.52%-259.36M
-94.65%1.17M
-130.37%-5.51M
-154.12%-8.24M
-210.75%-16.88M
17048.84%21.86M
145.16%18.13M
247.44%15.22M
-6.89%15.24M
-100.43%-129.00K
-635.75%-40.14M
85.46%-10.32M
-18.07%16.37M
99.74%29.89M
Net financing
459160.87%739.41M
-87.69%4.88M
92640.88%274.51M
125.87%568.00K
-99.93%161.00K
915.54%39.68M
-99.79%296.00K
---2.20M
--217.85M
-7471.21%-4.87M
4910.46%138.44M
-100.00%0.00
--0.00
-46.77%66.00K
1261.08%2.76M
-99.94%49.00K
-100.00%0.00
-89.48%124.00K
227.67%203.00K
35.46%88.86M

FAQs

What is the total revenue of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.04M, with a year-on-year change of 6.23M.

What are the current assets of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its current assets were 409.44M, with a year-on-year change of 45.76.

What are the total assets of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its total assets of Dianthus Therapeutics Inc were 530.92M, with a year-on-year change of 41.95.

What are the total liabilities of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its total liabilities of Dianthus Therapeutics Inc were 37.52M, with a year-on-year change of 74.27.

What is the total equity of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its total equity of Dianthus Therapeutics Inc was 493.40M, with a year-on-year change of 39.98.

What is the net operating income of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its net operating income of Dianthus Therapeutics Inc was -177.93M, with a year-on-year change of -74.68.

What is the net investment of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its net investment of Dianthus Therapeutics Inc was -122.83M, with a year-on-year change of 57.17.

What is the net financing of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its net financing of Dianthus Therapeutics Inc was 280.12M, with a year-on-year change of 9.59.

What is the Earnings Per Share (EPS) of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.20, with a year-on-year change of -64.82.

What is the net income of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its net income was -162.34M, with a year-on-year change of -91.05.

What is the net margin of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its net profit margin was -7973.33, with a year-on-year change of -485.08.

What is the Return on Equity (ROE) of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -38.38, with a year-on-year change of -17.75.

What is the Return on Assets (ROA) of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.88, with a year-on-year change of -16.84.

What is the operating profit of Dianthus Therapeutics Inc?

According to Dianthus Therapeutics Inc's FY2025 earnings report, its operating profit was -177.93M, with a year-on-year change of -74.68.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.